Get the Stockscreener App
2.75
1.79%
-0.05
Pre-market:
2.67
-0.08
-2.91%
Protagenic Therapeutics Inc stock is traded at $2.75, with a volume of 38,368.
It is down -1.79% in the last 24 hours and down -25.47% over the past month.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
See More
Previous Close:
$2.80
Open:
$2.7566
24h Volume:
38,368
Relative Volume:
0.02
Market Cap:
$1.62M
Revenue:
-
Net Income/Loss:
$-5.00M
P/E Ratio:
-2.3913
EPS:
-1.15
Net Cash Flow:
$-3.85M
1W Performance:
-9.39%
1M Performance:
-25.47%
6M Performance:
-26.60%
1Y Performance:
-74.15%
1-Day Range:
$2.60
$2.782
1-Week Range:
$2.60
$2.9974
52-Week Range:
$2.35
$15.54
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Name
Protagenic Therapeutics Inc
Sector
Industry
Phone
(212) 994-8200
Address
149 FIFTH AVENUE, NEW YORK
Compare PTIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
2.75 | 2.43M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Protagenic Therapeutics Inc Stock (PTIX) Latest News
Published on: 2025-08-13 04:40:19 - Newser
How to escape a deep drawdown in Protagenic Therapeutics Inc. Equity WarrantJuly 2025 Movers & Safe Capital Investment Plans - Newser
Analyzing drawdowns of Protagenic Therapeutics Inc. Equity Warrant with statistical tools2025 Key Highlights & Detailed Earnings Play Strategies - Newser
How to read the order book for Protagenic Therapeutics Inc.2025 Top Gainers & Consistent Profit Alerts - Newser
Protagenic Therapeutics Inc. Equity Warrant stock outlook for YEARJuly 2025 Fed Impact & Consistent Profit Focused Trading Strategies - Newser
Visualizing Protagenic Therapeutics Inc. stock with heatmapsJuly 2025 Opening Moves & Stock Market Timing Techniques - Newser
How to use Fibonacci retracement on Protagenic Therapeutics Inc.2025 Risk Factors & Daily Profit Maximizing Tips - Newser
What makes Protagenic Therapeutics Inc. stock price move sharplyJuly 2025 Fed Impact & High Conviction Investment Ideas - Newser
What’s the profit margin of Protagenic Therapeutics Inc.Short-Term Capital Expansion - thegnnews.com
What makes Protagenic Therapeutics Inc. Equity Warrant stock price move sharplyWatchlist Generator for Smart Money Signals - Newser
Is it too late to sell Protagenic Therapeutics Inc. Equity WarrantFree Low Volatility Stable Growth Picks - Newser
Can volume confirm reversal in Protagenic Therapeutics Inc.Safe Entry Strategy with High Win Rate - Newser
Protagenic Therapeutics Inc. stock outlook for YEARMomentum Trend Signal Weekly Recap Summary - Newser
Exit strategy if you’re trapped in Protagenic Therapeutics Inc.Investment Timing Strategy with Market Filters - Newser
Why Protagenic Therapeutics Inc. stock is on top investor watchlistsDay Trading Setup Forecast with Trend Model - Newser
Why Protagenic Therapeutics Inc. Equity Warrant stock attracts strong analyst attentionChart Risk Profile for Capital Preservation - Newser
Chart based analysis of Protagenic Therapeutics Inc. Equity Warrant trends - Newser
Protagenic Therapeutics Inc. Equity Warrant stock trend forecastFree Low Risk Buy Zone Opportunity Watch - Newser
Analyzing net buyer seller activity in Protagenic Therapeutics Inc. Equity WarrantStrong Buy Opportunity with Volume Support - Newser
Protagenic Therapeutics Inc. stock retracement – recovery analysisFree Consistent Profit Pattern Recognition Tools - Newser
Understanding Protagenic Therapeutics Inc.’s price movementPredictable Income Summary for Long-Term Trades - Newser
Key metrics from Protagenic Therapeutics Inc.’s quarterly dataFree Trade Setups With AI Powered Filters - Newser
How to integrate Protagenic Therapeutics Inc. Equity Warrant into portfolio analysis toolsConsistent Gain Plan with AI Support - Newser
Key resistance and support levels for Protagenic Therapeutics Inc. Equity WarrantIntraday Strategy with Real Time Monitoring - Newser
Earnings visualization tools for Protagenic Therapeutics Inc. Equity WarrantChart Signal and Short-Term Forecast Tracker - Newser
Is Protagenic Therapeutics Inc. Stock a Good Fit for Conservative InvestorsOversold Reversal Picks with Buy Zone - Newser
Why Protagenic Therapeutics Inc. stock attracts strong analyst attentionOversold Opportunity Scanner with RSI Data - Newser
Strategies to average down on Protagenic Therapeutics Inc.Trend Following Ideas with Volume Confirmation - Newser
Smart tools for monitoring Protagenic Therapeutics Inc.’s price actionLow Risk Trade Timing with Analysis Metrics - Newser
Sentiment analysis tools applied to Protagenic Therapeutics Inc. Equity WarrantEarnings Based Stock Performance Forecast - Newser
Volume spikes in Protagenic Therapeutics Inc. Equity Warrant stock – what they meanLow Drawdown Picks with Weekly Updates - Newser
Advanced analytics toolkit walkthrough for Protagenic Therapeutics Inc. Equity WarrantMulti-Bagger Detection with Trend Tools - Newser
Volatility clustering patterns for Protagenic Therapeutics Inc. Equity WarrantCommunity Picked Stocks with Trade Insights - Newser
Ranking Protagenic Therapeutics Inc. among high performing stocks via toolsFree AI Powered High Return Stock Calls - Newser
How to track smart money flows in Protagenic Therapeutics Inc.Trend Analysis for Safer Market Entries - Newser
Competitive Positioning of Protagenic Therapeutics Inc.: Is It Leading or LaggingEarnings Impact and Stock Reaction Analysis - Newser
Ranking Protagenic Therapeutics Inc. Equity Warrant among high performing stocks via toolsDaily Pick Forecast with Entry Zones - Newser
How strong is Protagenic Therapeutics Inc. Equity Warrant company’s balance sheetDiscover stocks with superior performance - Jammu Links News
How does Protagenic Therapeutics Inc. Equity Warrant compare to its industry peersBuild a diversified portfolio for risk management - Jammu Links News
Is Protagenic Therapeutics Inc. stock overvalued or undervaluedSuperior returns - Jammu Links News
What is Protagenic Therapeutics Inc. company’s growth strategySkyrocketing investment returns - Jammu Links News
When is Protagenic Therapeutics Inc. Equity Warrant stock expected to show significant growthBuild a portfolio with strong long-term growth - Jammu Links News
How does Protagenic Therapeutics Inc. compare to its industry peersMaximize returns with data-driven strategies - Jammu Links News
Is it the right time to buy Protagenic Therapeutics Inc. Equity Warrant stockBuild a winning investment strategy - Jammu Links News
What are Protagenic Therapeutics Inc. company’s key revenue driversInvest smarter with actionable trading signals - Jammu Links News
Published on: 2025-08-03 23:37:39 - Jammu Links News
Protagenic Therapeutics Inc Stock (PTIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.91%
3.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):